Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) major shareholder Financial Lp Hrt bought 4,252,767 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were bought at an average cost of $0.02 per share, with a total value of $85,055.34. Following the completion of the purchase, the insider directly owned 2,459,308 shares in the company, valued at $49,186.16. This represents a -237.13% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Financial Lp Hrt also recently made the following trade(s):
- On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The stock was sold at an average price of $0.06, for a total value of $44,127.72.
- On Thursday, June 4th, Financial Lp Hrt bought 843,622 shares of Aditxt stock. The shares were bought at an average cost of $0.08 per share, with a total value of $67,489.76.
- On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total value of $8,232.84.
- On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The stock was sold at an average price of $7.83, for a total value of $1,104.03.
- On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The shares were acquired at an average cost of $8.91 per share, with a total value of $24,057.00.
- On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total value of $3,588.30.
Aditxt Price Performance
Shares of NASDAQ ADTX opened at $0.01 on Wednesday. The company has a market capitalization of $8,894.40, a price-to-earnings ratio of 0.00 and a beta of 0.84. The business has a 50-day moving average of $4.60 and a two-hundred day moving average of $136.02. Aditxt, Inc. has a 1 year low of $0.01 and a 1 year high of $53,451.08.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on ADTX shares. Wall Street Zen raised Aditxt to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.
Read Our Latest Report on Aditxt
Aditxt Company Profile
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Read More
- Five stocks we like better than Aditxt
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
